Hamad Raza, Naheed Hashmat, Farah Shafi, Sameena Akram.
Role of trimetazidine (vestral MR) in acute myocardial infarction.
Pak J Med Health Sci Jan ;4(1):31-4.

Introduction: The coronary artery disease is the leading cause of death in U.S., Europe and in developed countries. Objectives: To assesses the clinical benefit of use of trimetazidine in acute MI along with thrombolytic therapy. 100 patients with acute MI were included in this study. Subjects and methods: This study was carried out in the Departments of Medicine at Sir Ganga Ram Hospital and Services Hospital, Lahore on 100 patients fulfilling the criteria for acute MI during the 1 year study period. Results:One hundred patients were included in group I and group II (50 patients each).In group –I, 50 patients were treated with thrombolytic therapy i.e. Streptokinase alone. In group- II, 50 patients were treated with streptokinase along with trimadizidine. These patients were followed up till six month and complications like arrhythmia, congestive cardiac failure, bleeding, re-infarction, angina and death were compared between two groups.

PakMediNet -Pakistan's largest Database of Pakistani Medical Journals - http://www.pakmedinet.com